ONCONOVA THERAPEUTICS INC (ONTX) Stock Balance Sheet
USA - NASDAQ:ONTX - US68232V8019 - Common Stock
0.9953 USD
0 (-0.47%)
0.9012 USD
-0.09 (-9.45%)
| MRQ (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | 25.24M | 38.80M | 55.10M | 19.00M | 22.70M | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | null | null | null | null | null | |||
| Receivables | 18.00K | 0 | 0 | 0 | 100.00K | |||
| Inventories | null | null | null | null | null | |||
| Other Current Assets | 1.75M | 500.00K | 300.00K | 700.00K | 600.00K | |||
| Total Current Assets | 27.01M | 39.30M | 55.40M | 19.80M | 23.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 26.00K | 0 | 0 | 100.00K | 100.00K | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | null | null | null | null | null | |||
| Other Non-Current Assets | 1.00K | 0 | 0 | 200.00K | 200.00K | |||
| Total Non-Current Assets | 27.00K | 100.00K | 100.00K | 200.00K | 200.00K | |||
| TOTAL ASSETS | 27.04M | 39.40M | 55.50M | 20.00M | 23.70M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | null | null | null | null | null | |||
| Accrued Expenses | 3.08M | 3.80M | 3.00M | 4.80M | 7.30M | |||
| Accounts Payable | 6.15M | 3.90M | 2.80M | 4.80M | 500.00K | |||
| Other Current Liabilities | 441.00K | 400.00K | 400.00K | 400.00K | 500.00K | |||
| Total Current Liabilities | 9.67M | 8.00M | 6.10M | 10.00M | 8.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | 2.85M | 3.00M | 3.20M | 3.80M | 3.80M | |||
| Total Non-Current Liabilities | 2.85M | 3.10M | 3.30M | 3.80M | 3.80M | |||
| TOTAL LIABILITIES | 12.52M | 11.10M | 9.40M | 13.80M | 12.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -478.45M | -463.70M | -444.70M | -428.60M | -403.40M | |||
| Additional Paid In Capital | 492.78M | 491.80M | 490.60M | 432.90M | 413.90M | |||
| Minority Interest | null | null | null | null | 0 | |||
| Common Shares | 210.00K | 200.00K | 200.00K | 1.90M | 1.10M | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | -30.00K | 0 | 0 | 0 | 0 | |||
| Shares Outstanding | 21.00M | 20.90M | 20.90M | 12.40M | 7.40M | |||
| Tangible Book Value per Share | 0.69117 | 1.3541 | 2.2057 | 0.5 | 1.5676 | |||
| Total Shareholders' Equity | 14.52M | 28.30M | 46.10M | 6.20M | 11.60M | |||
| TOTAL LIABILITIES AND EQUITY | 27.04M | 39.40M | 55.50M | 20.00M | 23.70M | |||
| Statistics | ||||||||
| Current Ratio | 2.79 | 4.91 | 9.08 | 1.98 | 2.83 | |||
| Return On Assets (ROA) | -74.67% | -48.12% | -29.12% | -125.80% | -90.72% | |||
| Return On Equity (ROE) | -139.07% | -67.00% | -35.05% | -405.81% | -185.34% | |||
All data in USD , ROIC based on taxRate of 0.21